Found 0 matching trials
Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
PHASE1The purpose of this study is to determine the safety of giving a normal fac...
Location
Stanford Medical School
Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
PHASE4The goal of this study is to determine if a fixed dose of 4-factor prothrom...
Prothrombin Complex Concentrate for Anticoagulant Reversal
PHASE3Patients on oral anticoagulants need rapid reversal of the anticoagulant ef...
Location
Clinical Trials Registration Coordinator
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
PHASE3Primary Objective:
To characterize the frequency of bleeding episodes (BE)...
Location
Investigational Site Number 0139
Joint Health Study
N/AThis is a prospective, non-randomized, controlled study to examine whether ...
Location
Orthopaedic Institute for Children at University of California Los Angeles
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
N/AThis observational, post-authorization, long-term follow-up study aims to i...
Location
American Thrombosis and Hemostasis Network
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
NAA non-randomized, open-label study to evaluate the safety, kinetics and eff...
Location
Institute of Hematology & Blood Diseases Hospital
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
PHASE3Primary Objective:
-To evaluate the efficacy of fitusiran compared to on-d...
Location
Investigational Site Number 0140
BeneFIX Drug Use Results Survey [All-Case Surveillance]
N/AThe survey is intended to investigate the following matters, etc. under the...
Location
Tokyo Medical University Hospital
Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients
PHASE3The purpose of this pivotal Phase 1/3 study is to determine the pharmacokin...
Location
Multiple Locations